Drugs / Influenza vaccine GSK2186877A formulation 2
Influenza vaccine GSK2186877A formulation 2
Trials 1 · a red edge is where a trial was stopped
| Phase | Registry id | Dates | Indication | Sponsor | Status | Outcome |
|---|---|---|---|---|---|---|
| Phase 1 | NCT01096056 | Apr → Dec 2010 | influenza | GlaxoSmithKline | Completed | No outcome recorded |
Evidence & citations 3 cited values
Every value below carries the sentence it was read from. 1 source stands behind the page.
| Field | Value | Cited text |
|---|---|---|
| Known as | Influenza vaccine GSK2186877A formulation 2 | ClinicalTrials.gov intervention name — accepted as the source's own label NCT01096056 ↗ |
| Modality | Vaccine | “influenza vaccine GSK2186877A formulation 2” NCT01096056 ↗ |
| Route | Intramuscular | “Intramuscular administration, 1 dose” NCT01096056 ↗ |